![Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives - Cancer Treatment Reviews Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/be766e60-9936-4b37-a793-d89c1bb49166/gr1.jpg)
Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives - Cancer Treatment Reviews
![Cancers | Free Full-Text | Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It? | HTML Cancers | Free Full-Text | Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It? | HTML](https://www.mdpi.com/cancers/cancers-12-03308/article_deploy/html/images/cancers-12-03308-g001.png)
Cancers | Free Full-Text | Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It? | HTML
![Efficacia di due diverse durate di chemioterapia adiuvante nel cancro del colon-retto - Fondazione Merck Serono Efficacia di due diverse durate di chemioterapia adiuvante nel cancro del colon-retto - Fondazione Merck Serono](https://www.fondazioneserono.org/wp-content/uploads/2018/05/dripbig.jpg)
Efficacia di due diverse durate di chemioterapia adiuvante nel cancro del colon-retto - Fondazione Merck Serono
Cetuximab in first line treatment of metastatic colorectal cancer | Barone | Farmeconomia. Health economics and therapeutic pathways
![Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1 - ESMO Open Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1 - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2812cd5f-87fc-417b-9192-8505f4ac7acf/gr1.jpg)
Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1 - ESMO Open
![Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC) - Annals of Oncology Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC) - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/15944f67-06af-4cee-a204-74a56abb67b9/gr1.jpg)
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC) - Annals of Oncology
![Chemioterapia e trattamenti loco-regionali per il tumore metastatico del colon-retto - Fondazione Merck Serono Chemioterapia e trattamenti loco-regionali per il tumore metastatico del colon-retto - Fondazione Merck Serono](https://www.fondazioneserono.org/wp-content/uploads/2019/06/coloncancer.jpg)
Chemioterapia e trattamenti loco-regionali per il tumore metastatico del colon-retto - Fondazione Merck Serono
![EPISODIO n. 1 - ASCO 2022 - Dostarlimab nel retto MSI e terapia adiuvante nel colon stadio II guidata da ctDNA EPISODIO n. 1 - ASCO 2022 - Dostarlimab nel retto MSI e terapia adiuvante nel colon stadio II guidata da ctDNA](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_720/images.spreaker.com/original/f01960684892dd5860af8fd05cdbe1d0.jpg)
EPISODIO n. 1 - ASCO 2022 - Dostarlimab nel retto MSI e terapia adiuvante nel colon stadio II guidata da ctDNA
![Tumore del colon-retto: Poliambulanza uno dei centri pilota nella riduzione della durata della chemioterapia adiuvante Tumore del colon-retto: Poliambulanza uno dei centri pilota nella riduzione della durata della chemioterapia adiuvante](https://www.poliambulanza.it/uploads/2018-5-8/500-0/shutterstock_1025461768.jpg)